MarketResearchReports.Biz

Skin Cancer Global Clinical Trials Review, H1, 2014

MarketResearchReports.Biz presents this most up-to-date research on"Skin Cancer Global Clinical Trials Review, H1, 2014"

 
Repost This

Albany, NY -- (SBWIRE) -- 06/25/2014 -- Skin Cancer Global Clinical Trials Review, H1, 2014" provides data on the Skin Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Skin Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Skin Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/skin-cancer-global-clinical-trials-review-h1-2014

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/208083

Table of Contents
Table of Contents2
List of Tables 4
List of Figures 5
Introduction 6
Skin Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Skin Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Skin Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/208083

In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Skin Cancer 25
Subjects Recruited Over a Period of Time 39
Clinical Trials by Sponsor Type 40
Prominent Sponsors 41
Top Companies Participating in Skin Cancer Therapeutics Clinical Trials 42
Prominent Drugs 44
Latest Clinical Trials News on Skin Cancer 45
Jan 27, 2014: Immune Design Announces Treatment of First Patient in Phase 1 Clinical Trial of ID-G100, an Investigational Immuno-Oncology Agent 45
Dec 19, 2013: Blaze Bioscience Announces Initiation of First-in-Human Phase 1 Clinical Study of BLZ-100 45
Nov 06, 2013: Aclaris Therapeutics Initiates IND-Directed Program for A-101 for the Treatment of Seborrheic Keratosis, Common Type of Skin Tumor 46
Feb 11, 2013: Gefitinib Shows Promise in Treating Skin Cancer, Study Finds 46
Jan 30, 2013: Silibinin Protects Against UV-induced Skin Cancer, Researchers Report 47
Clinical Trial Profiles 48
Clinical Trial Overview of Top Companies 48

Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz